Published in Vaccine Weekly, May 28th, 2003
Data presented from extensive safety studies in animals support the safety of this vaccine, named tgAAC09. These findings support clinical development of the vaccine, and human trials are targeted to begin later this year. The findings were presented during the 2003 Pediatric Academic Societies' (PAS) annual meeting by Philip R....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly